Theravance Biopharma (TBPH) Free Cash Flow (QoQ) (2013 - 2026)
Theravance Biopharma (TBPH) Free Cash Flow (QoQ) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Theravance Biopharma | 864.56 Mn | 469.90 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1,306.83% |
| Dec 31, 2025 | 6.70% |
| Sep 30, 2025 | -103.13% |
| Jun 30, 2025 | 383.45% |
| Mar 31, 2025 | 4,041.30% |
| Dec 31, 2024 | 79.04% |
| Sep 30, 2024 | -17.07% |
| Jun 30, 2024 | -299.91% |
| Mar 31, 2024 | 27.30% |
| Dec 31, 2023 | 38.93% |
| Sep 30, 2023 | 81.13% |
| Jun 30, 2023 | -9.29% |
| Mar 31, 2023 | -122.25% |
| Dec 31, 2022 | 431.56% |
| Sep 30, 2022 | -11.04% |
| Jun 30, 2022 | 43.60% |
| Mar 31, 2022 | 38.62% |
| Dec 31, 2021 | 7.76% |
| Sep 30, 2021 | 7.53% |
| Jun 30, 2021 | 29.82% |